|
Dr.Ziwei Liang Taiyuan University ofTechnology,Department of Biomedical Engineering, Taiyuan 030024, PR China. E-mail:Liangziweiguozhong@163.com Website:http://tylgswyxgc.tyut.edu.cn/info/1049/1681.htm |
Education
2010-2014 |
TaiyuanNormalUniversity, China |
Biological Sciences |
Bachelor |
2014-2017 |
SichuanUniversity, China |
Cellbiology |
Master |
2017-2020 |
FudanUniversity, China |
Biochemistry and Molecular Biology |
Ph.D. |
Professional Experience
2020.07- Present |
Taiyuan University of Technology, China |
Research interests
lTumor-Targeted Therapy
lPost-TranslationalModifications
lCancer Stem Cell
lFunctional Biomedical Materials
Selected publications
1.Ziwei Liang, Yanfang Yang, Yu He, Pengbo Yang, Xixi Wang, Gu He, Peng Zhang, Hongxia Zhu, Ningzhi Xu, Xia Zhao, Shufang Liang*.SUMOylation of IQGAP1 promotes the development of colorectal cancer.Cancer Lett.2017, 411:90-99.
2.Yuanyan Wei＃, Danfang Shi＃, Ziwei Liang＃, Yuming Liu＃, Yinan Li, Yang Xing, Weitao Liu, Zhilong Ai, Jianhui Zhuang, Xiaoning Chen, Qiang Gao, Jianhai Jiang*IL-17A Secreted from Lymphatic Endothelial Cells Promotes Tumorigenesis by Up-regulation of PD-L1 in Hepatoma Stem Cells.Journal of Hepatology .2019, 71(6): 1206-1215.
3. Yanfang Yang＃,Ziwei Liang＃, Zijing Xia, Xixi Wang, Yanni Ma, Zenghua Sheng, Qingjia Gu, GuoboShen, Liangxue Zhou, Hongxia Zhu, Ningzhi Xu, Shufang Liang*.SAE1 promotes human glioma progression through activating AKT SUMOylation-mediated signaling pathways.Cell Commun. Signal. 2019,17:82.
